DULSEVIA
60MG CPS ETD 30
| Maximum ex-factory price/Ex-factory price ? | 426,32 CZK |
|---|---|
| Legal basis of maximum ex-factory price/ex-factory price ? | Maximum ex-factory price announced under the law. |
Informace o základní úhradě
| Core reimbursement from health insurance ? | 408,66 CZK |
|---|---|
| Maximum reimbursement from health insurance ? | 601,90 CZK |
| Legal basis of reimbursement from health insurance ? | Reimbursement set by the law. |
| Indication restriction of reimbursement ? | Duloxetin je předepisován k léčbě diabetické neuropatické bolesti u pacientů, kteří neměli dostatečnou terapeutickou odpověď (nedošlo ke zmírnění bolesti alespoň o 50% dle VAS) nebo netolerovali léky první volby (amitriptylin, karbamazepin). Kontrola účinnosti léčby duloxetinem v této indikaci je provedena nejpozději po 6 týdnech a pokud nedošlo k dostatečné terapeutické odpovědi, není léčba dále indikována. |
| Prescribing doctor's specialisation ? |
Neurology, children's neurology Diabetology Algesiology, palliative care |
| Reporting limit ? | E: Unless it is advisable to transfer the prescription of the product to another doctor under paragraph 2 in light of the effect and safety of the product, the "E" symbol will mark the product in the decision. |
| Rough price for the final consumer ? | 617,80 CZK |
| Rough payment for the final consumer (for 1 prescribed package dispensed) ? | 15.9 CZK |
| Eligible extra payment ? | – |
| Eligible extra payment for individuals aged 65 and older ? | – |
cz